Repository logo
 

Complete Genome Sequence of MIDG2331, a Genetically Tractable Serovar 8 Clinical Isolate of Actinobacillus pleuropneumoniae

Published version
Peer-reviewed

Type

Article

Change log

Authors

Bossé, JT 
Chaudhuri, RR 
Li, Y 
Leanse, LG 
Fernandez Crespo, R 

Abstract

We report here the complete annotated genome sequence of a clinical serovar 8 isolate Actinobacillus pleuropneumoniae MIDG2331. Unlike the serovar 8 reference strain 405, MIDG2331 is amenable to genetic manipulation via natural transformation as well as conjugation, making it ideal for studies of gene function.

Description

Keywords

0604 Genetics, Basic Science, Genetics, Biotechnology

Journal Title

Genome Announcements

Conference Name

Journal ISSN

2169-8287
2169-8287

Volume Title

4

Publisher

American Society for Microbiology
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/G019274/1)
Wellcome Trust provided funding to Paul Coupland and Matthew Holden under grant number 098051. Biotechnology and Biological Sciences Research Council (BBSRC) provided funding to Janine T. Bosse, Roy R. Chaudhuri, Yanwen Li, Leon G. Leanse, Roberto Fernandez Crespo, Paul Coupland, Matthew Holden, Denise Mara Soares Bazzolli, Duncan J. Maskell, Dan Tucker, Brendan W. Wren, Andrew N. Rycroft, Paul R. Langford, and BraDP1t Consortium under grant numbers BB/ G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1. Biotechnology and Biological Sciences Research Council (BBSRC) provided funding to Paul R Langford under grant number BB/K021109/1. MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) provided funding to Denise Mara Soares Bazzolli under grant number PDE 201840/2011-1. This work was supported by a Longer and Larger (LoLa) grant from the Biotechnology and Biological Sciences Research Council (grant numbers BB/G020744/1, BB/G019177/1, BB/G019274/1, and BB/G018553/1), the UK Department for Environment, Food and Rural Affairs, and Zoetis (formerly Pfizer Animal Health) awarded to the Bacterial Respiratory Diseases of Pigs-1 Technology (BRaDP1T) consortium, a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number PDE 201840/2011-1) awarded to D.M.B., and a BBSRC Imperial-Brazil partnering award (BB/K021109/1) awarded to P.R.L. M.T.G.H. and P.C. were supported by the Wellcome Trust (grant number 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.